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Noninvasive ventilation
In 2012, the journal published several articles dealing
with the use of noninvasive ventilation (NIV) in patients
with acute respiratory failure (ARF). Carrillo et al. [1]
prospectively evaluated the characteristics and outcomes
of 184 patients with severe ARF due to community-
acquired pneumonia treated with NIV, and determined the
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factors predicting NIV failure and mortality. NIV was
successful in 63 % of patients. Confirming previous
findings, the authors found that patients with ‘‘de novo’’
ARF failed NIV more frequently than those with previous
cardiac or other respiratory disease (46 vs. 26 %).
Worsening radiologic infiltrate 24 h after admission,
maximum Sepsis-Related Organ Failure Assessment
(SOFA) score, and higher heart rate and lower PaO2/FiO2
after 1 h of NIV were among the factors predicting NIV
failure. NIV failure, maximum SOFA, and older age
independently predicted hospital mortality. In patients
with de novo ARF only, delayed intubation was consis-
tently associated with a decreased survival. In 13 patients
(six with chronic obstructive pulmonary disease), Piquil-
loud et al. [2] compared short-term patient–ventilator
interaction during NIV with pressure support (PS) and
neurally adjusted ventilatory assist (NAVA). As com-
pared with PS, NAVA improved patient–ventilator
synchrony during NIV by reducing trigger delay and
severe asynchrony and by abolishing ineffective efforts
and both delayed and premature cycling. Vaschetto et al.
[3] performed a pilot study to assess the feasibility of
using NIV to facilitate discontinuation of invasive
mechanical ventilation in patients with resolving hypox-
aemic ARF. Twenty patients randomly received
immediate NIV after early extubation or conventional
weaning. At the end of the study, arterial blood gas,
success of extubation, septic complications, ICU length of
stay, and mortality were similar, but the number of days
without invasive ventilation at day 28 was higher in the
NIV group than in the control group. The authors con-
cluded that, in a highly experienced centre, early
extubation followed by NIV is feasible and might facili-
tate liberation from mechanical ventilation in selected
patients with hypoxaemic ARF. These findings were
discussed in the editorial by Laghi and Fernandez [4].
Another study evaluated the optimal type and toler-
ance of the interface chosen for long-term noninvasive
positive pressure ventilation (NPPV) in children with
neuromuscular disease or thoracic scoliosis (n = 35),
obstructive sleep apnea with (n = 32) or without
(n = 21) maxillofacial deformity, or lung disease (n = 9)
[5]. All 25 children 2 years of age or younger, as well as
four older children, were fitted with custom-made nasal
masks; all other children were fitted with an industrial
nasal mask (50 %), a facial mask (16 %), or nasal prongs
(2 %). All patients with obstructive sleep apnoea used
interfaces with manufactured leaks, whereas all patients
with neuromuscular disease or thoracic scoliosis used
interfaces without manufactured leaks. Both types of
interfaces were used in patients with lung disease. The
interface had to be changed in 20 patients because of
discomfort (n = 16), leaks (n = 4), facial growth
(n = 3), skin injury (n = 2), or change of the ventilatory
mode (n = 2). A second or third mask change was nec-
essary in nine and four patients, respectively, suggesting
that the choice of the interface for NPPV in children is
determined by the patient’s age and the underlying
disease.
In bench studies Olivieri and co-workers [6] evaluated
NIV devices. The increasingly popular NIV can be pro-
vided with an increasing range of new equipment, both
ventilators and interfaces. To enable a comparison between
equipment the authors tried to develop standard references
for demand and effort, mode of generation and extent of air
leaks as well as impact on the respiratory mechanics of the
patient. Even terminology needs to be uniform. To this end
the authors used model tests aimed at standardising mea-
surement criteria to enable such comparisons.
The prediction of weaning outcome is relevant.
Ouanes-Besbes et al. [7] aimed to compare the performance
of NT-proBNP levels, plasma protein concentration,
haematocrit, and fluid balance for the preceding 24 h in
predicting the outcome of the two steps of weaning: (1)
spontaneous breathing trial (SBT), (2) extubation. A
prospective observational study of 143 patients who were
mechanically ventilated for more than 48 h (55 % COPD)
and were ready to wean was carried out. Patients under-
went an SBT and were extubated when they passed the
trial. Diagnostic tests were performed immediately before
the SBT. Of 143 patients, 80 (56 %) passed the SBT and
were extubated. Of these, two were reintubated for lar-
yngeal dyspnoea, 57 had no respiratory problem during
the next 48 h, and 21 developed post-extubation respira-
tory distress (26 %). Rescue NIV prevented reintubation
in 15 (71 %) patients. Only NT-proBNP was an inde-
pendent predictor of the occurrence of post-extubation
respiratory distress (OR 1.2; 95 % CI 1.09–1.4;
p = 0.003); the area under the ROC curve for NT-
proBNP to predict post-extubation respiratory distress
was 0.78 (95 % CI 0.67–0.89; p = 0.0001). It was con-
cluded that NT-proBNP levels at SBT help in the
prediction of post-extubation respiratory distress and
could identify the subgroup of extubated patients requir-
ing close observation and/or prophylactic NIV.
Work of breathing, monitoring and patient–ventilator
interaction
The assessment of work of breathing can prove useful in
mechanically ventilated patients. Vivier et al. [8] assessed
the feasibility and accuracy of ultrasonography to assess
diaphragmatic function and its contribution to respiratory
workload in 12 patients receiving NIV after extubation.
The authors reported a significant correlation between
diaphragmatic pressure–time product per breath and
thickening fraction of the diaphragm during tidal venti-
lation defined as (diaphragm thickness in the zone of
apposition at inspiration - thickness at expiration)/
thickness at expiration, suggesting that this method may
be useful to assess work of breathing in ICU patients. The
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coefficient of repeatability for interobserver reproduc-
ibility was, however, relatively high (15–18 %). Banner
et al. [9] assessed the usefulness of work of breathing for
predicting extubation outcome. In 97 patients (38 in a
training set and 59 in a prospective validation set), work
of breathing was noninvasively determined by use of an
artificial neural network during the spontaneous breathing
trial preceding extubation and compared to indices tra-
ditionally used to predict extubation outcome.
Noninvasive work of breathing had the greatest overall
predictive accuracy, the greatest sensitivity and positive
and negative predictive values compared to other indices.
In particular, a work of breathing no greater than 10 J/min
was observed in 95 % of successfully extubated patients.
The authors concluded that noninvasive work of breathing
warrants consideration for use in a complementary man-
ner with spontaneous breathing pattern data for predicting
extubation outcome.
Three studies dealt with technological innovations for
ventilatory monitoring and management. Blanch et al.
[10] performed a pilot, clinical study in a small number of
patients to validate a mathematical algorithm for auto-
matic, real-time detection of ineffective efforts during
expiration (Better Care). Better Care analysis was
compared with that of expert clinicians based on visual
examination of airway pressure and flow signals and with
an automated analysis based on the electrical activity of
the diaphragm. The results showed that Better Care was
able to identify ineffective efforts with an accuracy sim-
ilar to that of expert intensivists and the electrical activity
of the diaphragm. These results were discussed in the
accompanying editorial [11]. In 50 sedated, passively
ventilated patients, Arnal et al. [12] assessed the short-
term safety and efficacy of IntelliVent-ASV, a devel-
opment of adaptive support ventilation that automatically
adjusts ventilation and oxygenation parameters. As com-
pared with adaptive support ventilation, the use of
IntelliVent-ASV was associated with a decrease in
minute ventilation, tidal volume, respiratory rate, plateau
pressure, positive end-expiratory pressure (PEEP), and
FiO2, whereas respiratory mechanics and oxygenation
were similar and arterial carbon dioxide tension (PaCO2)
slightly increased. The authors concluded that in passive
patients and over a short period of time, IntelliVent-
ASV was safe and able to ventilate with less pressure,
volume and FiO2 while producing similar results in terms
of oxygenation.
Prigent et al. [13] evaluated the effects of a trache-
ostomy speaking valve (SV) on breathing–swallowing
interaction in a group of eight tracheostomised neuro-
muscular patients who were able to breathe spontaneously
and were studied with and without an SV. Breathing–
swallowing interactions were investigated by chin elec-
tromyography, cervical piezoelectric sensor, and nasal
and tracheal flow recording. Three water bolus sizes
(5, 10 and 15 ml) were tested in random order. The
authors’ conclusion was that in tracheostomised patients,
protective expiration towards the upper airway after
swallowing is restored by the use of an SV.
The state-of-the-art in electrical impedance tomogra-
phy (EIT) for ventilation and perfusion imaging was
reported in an interesting review [14]. EIT is a relatively
new technology used to image regional impedance dis-
tributions in a cross-sectional area of the body. The
authors focused on regional ventilation monitoring using
EIT. Several recently presented indices that are useful to
extract information from EIT image streams are descri-
bed. Selected experimental and clinical findings are
discussed with respect to future routine applications in
intensive care. The authors also provide a number of
clinical scenarios in which EIT may be a useful as a
diagnostic or monitoring tool. Finally, past and ongoing
research activities aimed at obtaining cardiac output and
regional perfusion information from EIT image streams
are summarised. The authors concluded that EIT will
change the way we treat mechanically ventilated patients.
Patroniti et al. [15] evaluated the effect of a wide
range of assistance levels during NAVA and pressure
support ventilation (PSV) on respiratory pattern, breath-
ing variability, and incidence of tidal volumes (VT) above
8 and 10 ml/kg in ARF patients, reporting that increasing
NAVA levels were associated with no effect on respira-
tory rate, a small increase in VT, and an increase in VT and
EAdi variability. An effective decrease in EAdi occurred
at NAVA levels below 2–2.5 cmH2O/lV, while pre-
serving respiratory variability and low risks of VT above 8
or 10 ml/kg.
The same innovative mode was also evaluated in
paediatric patients by de la Oliva et al. [16] to determine
if NAVA improves asynchrony, ventilatory drive, breath-
to-breath variability and COMFORT score when com-
pared to PS. Four sequential 10-min periods of data were
recorded after 20 min of ventilatory stabilisation (wash-
out) at each of the following settings: baseline PS with the
ventilator settings determined by the attending physician
(1-PSb); PS after optimisation (2-PSopt); NAVA level set
so that maximum inspiratory pressure (Pmax) equalled
Pmax in PS (3-NAVA); the same settings as in 2-PSopt
(4-PSopt). The authors concluded that NAVA as compared
to optimised PS results in improved synchrony, reduced
ventilatory drive, increased breath-to-breath mechanical
variability and improved patient comfort.
A study by Fine-Goulden and co-workers [17] analysed
the monitoring of electrical activity in the diaphragm in
children with neuromuscular and respiratory control dis-
orders. The authors used NAVA with an oesophageal
catheter to measure the diaphragm activity. They studied
the lowest achievable level of respiratory support in six
ventilator-dependent patients. Their major finding was that
the respiratory dynamic patterns were morbidly abnormal
despite no clinical signs. The authors conclude that using
NAVA enables a minimally invasive diagnostic adjunct in
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children with neuromuscular and respiratory control dis-
orders who are ventilator dependent.
In a study of physiological dead space Sinha and Soni
[18] compared classic dead space measurements using a
Douglas bag method with volumetric capnography where
expiratory gas flow and CO2 are continuously measured.
They made comparisons in critically ill patients and found
a good agreement between the physiological dead space
by the Douglas bag technique and the volumetric cap-
nography. One can discuss the difference between the
Bohr and Enghoff dead spaces, the latter being measured
by replacing alveolar CO2 by arterial CO2. The former
will calculate a true dead space, the latter will be influ-
enced by gas exchange abnormalities of other kinds.
Anyway, the volumetric capnography was considered
useful in studying their critically ill patients.
PaO2 and O2Sat
Eastwood et al. [19] retrospectively assessed the rela-
tionship between arterial oxygen tension (PaO2) and
hospital mortality in 152,680 patients undergoing
mechanical ventilation in 150 ICUs in Australia and New
Zealand. Mean PaO2 was 152 mmHg and mean inspired
fraction of oxygen (FiO2) was 62 %; about 50 % of
patients had hyperoxia (PaO2 [ 120 mmHg). After
adjusting for baseline characteristics including the Sim-
plified Acute Physiology Score (SAPS) II, there was no
relationship between PaO2 or hyperoxia and mortality.
Subgroup analysis in patients with high or low FiO2 and
according to diagnostic categories (elective surgery, sep-
sis, respiratory diagnosis and surgical procedures) was
consistent with the findings in the overall cohort. Thus the
impact of early hyperoxia on mortality remains uncertain.
In a study by Nesseler and co-workers [20] pulse
oximetry with forehead and finger sensors was compared in
patients in shock, a condition when finger perfusion may be
reduced. In a fair sample of 32 patients, the forehead sensor
readings never failed, whereas a few finger sensor
recordings did. As hypothesised the forehead measure-
ments were more accurate when compared with the arterial
saturation in their critically ill patients and the authors
recommend the use of this instead of the finger sensor.
Sleep
Sleep disturbances are extremely common in critically ill
patients and sedatives are often used to promote sleep. In
12 ICU patients ventilated on assisted modes, Kondili
et al. [21] compared sleep quality with and without pro-
pofol infusion (targeted to a Ramsay sedation score of 3)
during two consecutive nights. In all patients, sleep
architecture was abnormal during both nights, with no
difference in sleep efficiency, sleep fragmentation, and
sleep stage distribution. In addition, propofol infusion
suppressed the REM stage and further worsened the poor
sleep quality in these patients. These effects could not be
explained by changes in respiratory variables, in gas
exchange or in patient–ventilator asynchrony, which were
similar during the two study nights.
ARDS
Several articles dealing with acute respiratory distress
syndrome (ARDS) were published in the journal in 2012.
Ferguson et al. [22] provided an expanded discussion of
the rationale underlying the development of the recently
published Berlin definition of ARDS [23], and provided
further supplementary material to facilitate its application.
According to the new definition, ARDS is characterised
by an acute onset (within 1 week of a known clinical
insult or new/worsening respiratory symptoms), presence
of bilateral opacities on chest radiograph or computed
tomography, and respiratory failure not fully explained by
cardiac failure or fluid overload (objective evaluation is
required to exclude hydrostatic oedema if no risk factor is
present). ARDS is categorised as mild, moderate or severe
according to the PaO2/FiO2 value measured with a PEEP
of at least 5 cmH2O. In ARDS, excessive lung deforma-
tion or strain can occur during mechanical ventilation, and
it may be linked to biological lung response. Gonza´lez-
Lo´pez et al. [24] studied the relationship between lung
strain and biomarkers of matrix remodelling and inflam-
mation in mechanically ventilated patients with ARDS.
Patients with high strain had greater concentrations of
IL-6 and IL-8 in bronchoalveolar lavage fluid than
patients with normal strain, and matrix remodelling
markers, gas exchange, and respiratory IL-6 and IL-8
concentrations in bronchoalveolar lavage were correlated
with strain values. The authors conclude that increased
strain is associated with a proinflammatory lung response
in these patients; mechanics were similar.
The receptor for advanced glycation end products
(RAGE) is a pattern-recognition receptor and evolution-
ary member of the immunoglobulin superfamily that is
involved in the host response to infection, injury and
inflammation. It exists in two forms: membrane-bound
and soluble forms (sRAGE). The soluble form, sRAGE, is
a decoy receptor and competitively inhibits membrane
RAGE activation. RAGE is constitutively expressed
abundantly in the lung under basal conditions. This
expression is enhanced during inflammatory states such as
with acute lung injury (ALI) and ARDS. A review by Guo
et al. [25] summarised the characteristics of RAGE,
RAGE isoforms, RAGE ligands, and signalling pathways
in the pathogenesis of ALI and ARDS. Additionally, the
review explores the potential of RAGE as an important
therapeutic target in ALI/ARDS. The authors concluded
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that a complete understanding of the relationship between
RAGE and other receptors will be beneficial in formu-
lating potential therapeutic approaches and limiting the
RAGE ligation may modulate the intensity of an over-
whelming pulmonary inflammatory response.
Two papers evaluated health-related quality of life
together with physical and psychological disability in
survivors of ARDS. Chiumello et al. [26] compared
1-year pulmonary function and quality of life in 26 sur-
vivors of ARDS previously ventilated in supine or prone
position. In the whole population, 1-year mortality rate
was high (60 %), whereas pulmonary function, gas
exchange and lung computed tomography scan analysis
were within normal values. Health-related quality of life
was similar to that of healthy subjects, but these patients
showed an impairment of daily activity specifically due to
pulmonary disease. No difference was observed between
groups in any of these variables, except for overinflated
tissue which was higher in patients treated in prone
position. Cox et al. [27] assessed coping ability (i.e. the
adaptive response aimed at diminishing the physical,
emotional and psychological burden that is linked to
stressful life events and daily challenges) in ICU survi-
vors (35 % with ALI) and their informal caregivers. A
telephone-based coping skills training intervention was
then developed and evaluated in survivors of ALI and
their caregivers. ICU survivors and their caregivers used
adaptive coping infrequently, a pattern that was strongly
associated with psychological distress. The telephone-
based coping skills training intervention was feasible,
acceptable and associated with a decrease in scores of
psychological distress, more evident among patients than
informal caregivers. These improvements were associated
with adaptive coping and high self-efficacy. The authors
conclude that the novel telephone-based coping skills
training intervention may reduce psychological distress
among patients and caregivers.
Extracorporeal support in ARDS
Three articles dealt with the use of extracorporeal support
in patients with respiratory failure. Grasso et al. [28]
evaluated whether partitioning of respiratory mechanics to
target values of end-inspiratory transpulmonary pressure up
to 25 cmH2O may led to a change of ventilatory strategy
allowing one to improve oxygenation thus avoiding an
inappropriate use of extracorporeal membrane oxygenation
(ECMO). Among 14 patients with influenza A(H1N1)-
associated ARDS referred for ECMO, seven patients
showed lower values of end-inspiratory transpulmonary
pressure (17 vs. 27 cmH2O): in these patients, raising
PEEP to obtain an end-inspiratory transpulmonary pressure
of 25 cmH2O improved oxygenation and allowed one to
keep up the conventional ventilatory treatment without
having to turn to ECMO. The authors concluded that, in
some patients with influenza A(H1N1)-associated ARDS,
abnormalities of chest wall mechanics may be present: in
these patients, titrating PEEP to the end-inspiratory pres-
sure of the respiratory system may overestimate the
incidence of refractory hypoxaemia leading to inappropri-
ate use of ECMO. This article was accompanied by an
editorial by Richard and Marini [29].
In extracorporeal veno-venous support, the positioning
of the cannula is important but often difficult to deter-
mine. Ko¨rver and co-workers [30] used ultrasound
dilution to optimise the position of a double lumen
catheter to achieve maximum recirculation. This was a
helpful adjunct to the visualisation of the catheter position
but the technique should also be tested by other clinicians
before it could be considered safe.
A review article focused on the circuit components
and management of adult patients receiving ECMO for
respiratory failure [31]. Hollow-fibre oxygenators and
Mendler-designed centrifugal pumps have replaced the
old silicon oxygenators and roller pumps. Advances in
cannula technology allow greater ease of patient posi-
tioning, in some cases facilitating extubation and
ambulation on ECMO. Improvements in ECMO circuitry
have led to a reduction in heparin and blood product
requirements, with consequently fewer complications.
Greater understanding of severe ARDS has allowed cli-
nicians to successfully support adults on ECMO.
Nowadays, this technique is safer, cheaper and simpler
than in previous eras. Prospective studies of ECMO for
adult respiratory failure are underway. Contemporary
ECMO in awake, potentially ambulant patients to provide
short-term support for those with acute, reversible respi-
ratory failure and as a bridge to transplantation in those
with irreversible respiratory failure is now ready for
widespread evaluation. This review is accompanied by an
editorial comment by Alan H. Morris [32].
In 42 patients with hypercapnic ARF who had failed
NIV, Kluge et al. [33] performed a retrospective, matched
case–control study to assess feasibility, safety and effec-
tiveness of pumpless extracorporeal carbon dioxide removal
(ECCO2r) as compared with conventional mechanical
ventilation. Nineteen out of 21 patients in the ECCO2r
group did not require intubation. In these patients, PaCO2,
pH and respiratory rate significantly improved within 24 h;
bleeding (two major and seven minor) was the main com-
plication. There was no difference in hospital length of stay
or short-term and long-term mortality between groups, but
the duration of invasive support and the tracheostomy rates
were lower in the ECCO2r group. These results suggest that
ECCO2r can be a feasible option to avoid intubation and
invasive mechanical ventilation in selected patients with
hypercapnic ARF not responding to NIV.
Gottlieb et al. [34] performed a retrospective analysis
of 100 mechanically ventilated patients (60 also under
extracorporeal support) accepted for high-urgency lung
transplantation in a single German centre to assess
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outcome and identify factors associated with survival.
Sixty patients were transplanted, 38 died while on the
waiting list and two recovered. One-year survival rates
were 36 % for all candidates: it was 57 % in transplanted
patients and 5 % in non-transplanted candidates
(p \ 0.01). SAPS greater than 24, procalcitonin level
greater than 0.5 lg/l and any escalation of bridging
strategy were independent predictors of mortality. The
authors concluded that (1) high-urgency lung transplan-
tation improves 1-year survival in critically ill, ventilated
candidates; and (2) prognostic factors can help identify
suitable candidates.
Sedation during mechanical ventilation
Several studies have also been dedicated to new sedation
strategies in mechanically ventilated patients. Oto et al. [35]
evaluated sleep continuity in mechanically ventilated
patients during dexmedetomidine infusion by recording
polysomnography (PSG) for 24 h in mechanically ventilated
patients sedated with dexmedetomidine. Dexmedetomidine
(0.2–0.7 lg/kg/h) was administered intravenously to main-
tain the Richmond Agitation Sedation Scale between -1 and
-4 only during the night-time (9.00 p.m.–6.00 a.m.). The
authors concluded that in mechanically ventilated patients,
night-time infusion of dexmedetomidine preserved the day–
night cycle of sleep but induced severely disturbed sleep
architecture without evidence of SWS or REM sleep.
Dexmedetomidine was also evaluated by Burbano
et al. [36] in a retrospective study designed to describe
changes in haemodynamic variables, sedation, and pain
score after discontinuation of prolonged infusions of
dexmedetomidine in a paediatric population of critically
ill cardiac patients, suggesting that tachycardia, transient
hypertension, and agitation are frequently observed in
paediatric cardiac intensive care unit patients after dis-
continuing prolonged dexmedetomidine infusions.
Paediatric
Respiratory
The monitoring and study of lung ventilation in small,
sick infants is often hampered by difficulties in obtaining
reliable measurements. Advances in ventilators incorpo-
rating accurate flow measurement systems have in recent
years started to enable changes in the way we ventilate
small babies. Duman and colleagues [37] have, for
example, recently shown the feasibility of deploying a
‘volume guarantee’ mode of ventilation in very small
infants using a ventilation system incorporating accurate
measurements of tidal volume. The development of EIT
has likewise enabled researchers to better study the
diseased lung in very small subjects. Bhatia et al. [38]
have shown, in a piglet model, that EIT can reliably
determine the presence of very small pneumothoraces
before significant changes in clinical parameters. Mie-
dema et al. [39] reported on the measurement of lung
volume with EIT in preterm infants in whom lung volume
and regional time constants were assessed. The impor-
tance of these studies comes not only from their insights
into lung recruitment but also from the potential useful-
ness of EIT in a clinical setting i.e. the assessment of lung
volume or detection of pneumothorax in very small
infants [39].
Controversy persists about the relevance of angiotensin-
converting enzyme insertion/deletion (I/D) polymorphisms
in disease severity and outcomes in ARDS. Whilst some
adult studies have suggested ACE gene I/D polymorphism
increases susceptibility or risk of mortality in patients with
severe sepsis or with sepsis-induced ARDS [40], others
[41] have failed to demonstrate such associations. Cruces
et al. [42] compared 60 children with ARDS to 60 controls
and found an increase in the frequency of the ACE I/D
genotype in the ARDS group, although severe hypoxaemia
was less frequent in patients with the D allele. Further
explorative studies are awaited with interest.
Over the past year we have published a number of
reports on aspects of ventilatory care in children. Whilst
positive pressure ventilation is a relatively mature tech-
nology, innovation continues to improve patient care. Da
Silva et al. [43] presented a report of a small randomised
controlled trial of three doses of nebulised L-epinephrine
in children with post-extubation stridor and found no
evidence of a dose–response relationship with the doses
administered. This is perhaps unsurprising, as with any
nebulised drug, the amount of drug actually delivered to
the airway depends significantly on the child’s tidal and
minute volumes and the duration of nebulisation, rather
than the mass of drug in the nebuliser [43]. The paper by
Ganu et al. [44] presents a series of infants requiring
respiratory support for bronchiolitis, the most common
cause of PICU admission in infancy. Over a 10-year
period they documented an increase in the use of nonin-
vasive ventilatory techniques associated with a decreased
PICU length of stay. It is sobering to recall that the first
description of noninvasive ventilation (CPAP) in bron-
chiolitis was published by Beasley and Jones in 1981
[45]. From noninvasive and long-term ventilation to the
ultimate respiratory support technique—ECMO, a report
by Smalley et al. [46] presents a 23-year experience of the
use of ECMO in a single Australian paediatric centre.
Since 2005, 88 % of children supported with ECMO for
refractory pneumonia survived, suggesting that ECMO is
a technically successful support technique in this group of
children. Direct comparisons across centres are, however,
fraught with difficulty not least because of case mix,
selection and management variability. Finally, the report
by Paulides et al. [47] reminds us that not all ventilation
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takes place in hospital, and that not all survivors of
intensive care are independent of mechanical ventilators.
The authors describe a series of 197 children started on
home mechanical ventilation between 1979 and 2009. In
the early stages, ventilation was mainly provided for boys
with respiratory failure due to neuromuscular disorders. In
the third decade of the series, many more young children
were supported, reflecting the increase in survivors of
complex neonatal and paediatric care requiring long-term
ventilatory support and the development of ventilatory
equipment designed for use in small children.
Cardiovascular
Mortality in paediatric cardiac surgery has fallen dramati-
cally over the past 20 years. The focus in the current era is
on reducing morbidity through prediction, prevention and
anticipatory management of cardiac critical illness and
perioperative care. Care of children with congenital heart
disease often requires prolonged periods of complex
intensive care with prolonged central venous access
increasing risk of venous thrombosis. Thrombi in the
central veins impair placement of central venous catheters
making vascular access a challenge, and limit or prevent
the establishment of cavopulmonary connections to secure
pulmonary blood flow. Thrombotic occlusion of femoral
veins can impede the performance of cardiac catheterisa-
tion for diagnostic or therapeutic interventions. Todd
Tzanetos [48] used ultrasound surveillance and serial
measurements of biomarkers of coagulation and fibrino-
lytic pathways to determine the prevalence of thrombus
and to describe the time course of biomarkers of coagu-
lation and fibrinolysis in a group of 16 children undergoing
early stage palliation for complex congenital heart disease.
Thrombus was detected in 31 % of 16 babies studied
despite the administration of heparin and aspirin, with
impaired ventricular function, low antithrombin III and
increased tissue plasminogen activator levels being asso-
ciated with the occurrence of thrombus. There is no
consensus on how thrombotic risk should be managed in
these vulnerable patients, and larger structured studies are
needed to further explore risk factors and treatment strat-
egies for central venous thrombosis. Algra et al. [49]
studied a cohort of 412 children following cardiac surgery
and detected infection defined by Center for Disease
Control definitions in 25 % of them. Of the patients
developing infections, 26 % developed surgical site
infections and 25 % bloodstream infections. A panel of
clinical variables available to bedside clinicians at 48 h
after cardiac surgery were subjected to regression analysis,
and a simple bedside ‘infection prediction’ rule including
age (\6 months), delayed sternal closure ([48 h) and
PICU stay ([48 h) was tested and shown to have a positive
predictive value of 54.5 %, and negative predictive value
of 79.5 %. Whilst the rule is helpful it is probably no
surprise for experienced intensivists to learn that smaller
children, sick enough to stay in for more than 48 h with an
open sternum are at risk of infection. Those interested in
this topic should also read the paper by Barker et al. [50]
which reports data derived from the large US Society of
Thoracic Surgeons database. Clinically important ‘low
cardiac output’ is a common complication seen in infants
and young children following cardiac surgery. Wernovsky
et al. [51] developed a descriptive inotrope score (IS) as a
means of comparing levels of inotropic support in a pae-
diatric critical care setting. Gaies et al. [52] updated the
original IS adding noradrenaline and ‘new’ drugs, milri-
none and vasopressin, naming this the vasoactive inotrope
score (VIS). Davidson et al. [53] recently undertook an
evaluation of the VIS and IS in children following cardiac
surgery and determined that a higher VIS at 48 h following
cardiac surgery is strongly associated with poorer short-
term outcomes including length of ventilation and PICU
stay. VIS was superior to IS in predicting short-term out-
come. The VIS may soon have to be modified again, if the
use of levosimendan gains traction in paediatric cardiac
critical care [53]. Ricci et al. [54] recently reported on its
use in a small randomised controlled trial of levosimendan
versus ‘usual inotropes’ in this population. Children were
allocated to receive either levosimendan, a novel inodilator
agent belonging to the family of calcium sensitiser agents,
or ‘usual inotropic therapy’. The incidence of clinically
assessed ‘low cardiac output’ was lower in the levosim-
endan group than in the control patients (37 vs. 61 %) [54].
Whilst the positive inotropic and vasodilating properties
and unique pharmacodynamics suggest a strong rationale
for the use of levosimendan in paediatric perioperative
care, it is a great shame that despite pressure from the
clinical community, the drug’s manufacturer has so far not
conducted or supported any sizable clinical trials in chil-
dren. In a prospective observational study, Hassinger et al.
[55] hypothesised that elevated preoperative levels of
asymmetrical dimethylarginine (ADMA), an endogenous
competitive inhibitor of nitric oxide synthase which is
known to be associated with disruption of endothelial
function, might be associated with worse outcomes fol-
lowing paediatric cardiac surgery. ADMA levels were
measure before cardiac surgery in 100 patients aged
0–18 years. Raised ADMA levels were found in 29
(29 %). Using logistic regression including a range of
common short-term clinical outcomes, the authors deter-
mined that preoperative ADMA level (odds ratio 452.9;
95 % CI 7.9, 999; p = 0.003), cardiopulmonary bypass
(CPB) time (odds ratio 1.03; 95 % CI 1.01, 1.05;
p = 0.002) and peak inotrope score (odds ratio 1.27; 95 %
CI 1.01, 1.59; p = 0.042) carried independent risk for poor
short-term outcomes. Mastropietro et al. [56] sought to
investigate the paradox that some children appear to have
increased arginine vasopressin (AVP) levels following
cardiac surgery whilst others who are hypotensive respond
favourably to exogenously administered AVP. A great
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difficulty in studying AVP is its short half-life and
demanding assay techniques. Copeptin is a more stable and
easily measured product of pro-AVP metabolism and may
therefore act as a useful surrogate for endogenous AVP
production. The investigators found that relative AVP
deficiency occurred in a portion of infants and children
following cardiac surgery. Plasma AVP and copeptin
concentrations were positively associated in these patients,
supporting a basis for additional studies of larger cohorts of
children to determine if copeptin will prove useful in
identifying these patients and therefore children who could
benefit from exogenous AVP administration.
The maintenance of stable haemodynamic conditions
whilst inducing sedation of anaesthesia during critical
illness is challenging. Some of the most commonly used
sedatives in critical care such as midazolam and propofol
are poorly tolerated in cardiovascularly compromised
children. Etomidate, an alternative sedative-anaesthetic
has a more favourable cardiovascular profile but is asso-
ciated with competitive inhibition of cortisol production
which itself may be harmful unless supplemental corti-
costeroid is given. The inert gas xenon has long been
recognised as an effective inhaled anaesthetic agent. Its
rarity in the atmosphere and therefore its expense have to
date severely limited its clinical application. Chakkara-
pani et al. [57] recently reported the effect of 18 h 50 %
xenon (Xe) inhalation at normothermia (NT 38.5 C) or
hypothermia (HT 33.5 C) on mean arterial blood pres-
sure, inotropic support and heart rate (HR) following an
induced perinatal global hypoxic-ischaemic insult (HI) in
newborn pigs. Xe maintained stable blood pressure,
thereby reducing the inotropic support requirements dur-
ing and after administration independently of induced
HT-current neonatal encephalopathy treatment. If supply,
delivery and recapture issues can be resolved, Xe may in
future offer haemodynamic benefits during neuroprotec-
tion and also in other haemodynamically critical
situations in paediatrics such as the induction of anaes-
thesia in children with sever septic shock or end-stage
heart failure (cardiomyopathy, acute fulminant myocar-
ditis). Whilst ‘myocardial depression’ or ‘low cardiac
output’ are often imputed from clinical findings in neo-
nates and young children in the perioperative period,
routine measurement of cardiac output is both difficult
and as yet of unproven benefit in patient management
[57]. Grollmuss et al. [58] investigated the use of a non-
invasive and continuous method of measuring stroke
volume, electrical velocimetry (EV) with intermittent
transthoracic Doppler measurements, and found the two
methods to be interchangeable. EV has the potential to
become a useful tool for continuous cardiac output mea-
surement and guiding goal-directed therapy in critically
ill infants with heart failure. Even blood pressure can be
challenging to measure in the critically ill preterm neo-
nate [58]. Konig et al. [59] studied 60 infants of less than
32 weeks gestation and compared noninvasive cuff
measurements with intra-arterial measurements obtained
from umbilical arterial catheters. Although the authors
found that overall the average differences between inva-
sive and noninvasive measurements were acceptable, the
range of under- and overestimation was large, making
reliance on noninvasive measurements in guiding circu-
latory management ‘problematic’. Clearly better
cardiovascular noninvasive monitoring methods are nee-
ded for our smallest patients. The majority of papers
published in the paediatric pages of the journal relate to
critical care undertaken in the developed world. Nguah
et al. [60] remind us of the huge burden of critical illness
in underdeveloped and developing countries, and what
can be achieved in those settings. These investigators
reported on observations of cardiac function and haemo-
dynamic status of 183 children with severe malaria at
presentation and after recovery, including details of
echocardiographic evaluation of 121 children in the
cohort. There is huge potential for studies in sepsis in
such settings which have the potential both to improve
local clinical care and provide key populations for clinical
trials with potentially worldwide application, as we have
recently seen from the FEAST trial [61].
Cyclosporine has been shown to reduce myocardial
cell death following ischaemia–reperfusion. Therefore
Gill et al. [62] hypothesised that cyclosporine treatment
may attenuate asphyxia-related intestinal injury in
neonates. In an asphyxiated newborn piglet model,
anaesthetised asphyxiated piglets were block-randomised
to receive cyclosporine (10 mg/kg) or placebo (normal
saline) boluses at 5 min of reoxygenation (n = 8/group).
Within 2 h of hypoxia, piglets had cardiogenic shock with
hypotension and acidosis and decreased superior mesen-
teric perfusion. Cyclosporine treatment increased superior
mesenteric arterial (SMA) flow (114 ± 6 vs. 78 ± 19 %
of baseline of controls, respectively) with improved
intestinal tissue lactate (all p \ 0.05) [62].
This is the first study to demonstrate that post-resus-
citation administration of cyclosporine improves
mesenteric perfusion and attenuates necrotising entero-
colitis (NEC)-like intestinal injury in newborn piglets
following asphyxia-reoxygenation.
Outcomes, quality and safety
Simple simulation techniques, as exemplified by practical
basic life support training, have been in medicine for
many years. In the aviation industry, sophisticated simu-
lators are used to facilitate whole crew (team) training and
this model has recently been adopted for the training
of medical teams. Initially purpose-built simulation ‘labo-
ratories’ were developed, and more recently the availability
of portable high-fidelity simulation equipment has enabled
simulation to take place in clinical facilities. Stocker et al.
[63] conducted a prospective, single-centre, longitudinal
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study over the first 2 years of an embedded clinical simu-
lation programme involving a total of 219 paediatric health-
care professionals. Approximately 90 % of participants
rated the simulation training as being effective in improving
their practical care delivery and in their ability to commu-
nicate and work effectively in a team. In a longitudinal
analysis there was a stepwise significant (p \0.05) increase
of confidence of participants, with a significantly
(p\ 0.001) higher confidence in participants who had
attended at least three sessions (90.7 vs. 61 %). Repeated
exposure to in situ simulation appeared to be more bene-
ficial than isolated exposure [63]. Two studies recently
reported in the journal by Booth et al. [64] and Martinez-
Anton et al. [65] focussed on improving patient safety in
PICUs by implementing intervention programmes aimed at
reducing prescribing errors. Martinez-Anton standardised
resources for prescribers and re-educated prescribers on
good prescribing practice. Prescriptions were studied over
4 months before and after a 12-month intervention period.
The overall error rate reduced from 34.2 % prior to the
intervention to 21.7 %. Booth focussed on an intervention
involving daily error feedback, achieving an absolute risk
reduction of 44.5 % (95 % CI 40.8–48 %). These are
clinically important reductions which potentially reduced
harm to patients and their associated costs. Of course some
change may have occurred through a Hawthorne effect,
although this appears to be unlikely as Martinez-Anton
reported that error rates actually increased with time during
their initial (pre-intervention) observation period. It would
be of great interest to know whether the improvements
reported by these investigators were sustained over time,
and if so how that was achieved.
Severity of illness scores such as PRISM and PIM are
now widely used in paediatric critical care to risk adjust
mortality data which allows assessment of unit perfor-
mance and in particular comparison between different units
within a health-care system. The revised Paediatric Index
of Mortality score (PIM2), originally developed in the UK
and Australia, uses data readily available at the point of
PICU admission and has been validated in a number of
different populations. Imamura et al. [66] recently assessed
data from 2,536 children admitted to a large PICU in
Japan, of whom 62 died. PIM2 was found to have excellent
discriminatory power, good calibration and therefore to be
a potentially useful tool in the assessment of quality of care
in Japanese PICUs. Likewise, Leteurtre et al. [67] sought to
compare the performance of PIM2 in 14 French and 1
Belgian PICUs. The authors undertook a recalibration of
the score in both the French-Belgian (FB) and Great
Britain and Ireland (GBI) data sets. PIM2 score and re-
calibrated PIM2 scores were found to perform well in both
the populations, whereas the version recalibrated using the
FB data, whilst performing well in that population, was
poorly calibrated when applied to the GBI data. The most
important finding of this study was that the PIM2 score was
valid in the FB population, a result which is encouraging as
moves are made towards a Europe-wide paediatric inten-
sive care registry. PIM2 may well evolve in time as
improvements, or at least changes, in paediatric intensive
care evolve with time. Scores can be updated by recali-
bration exercises as described by Leteurtre, in which the
algorithm generating the score is changed whilst using the
same data elements. More radical evolution of a score can
be undertaken by adding additional more discriminatory
data elements. Morris et al. [68] reported on the utility of
substituting admission blood lactate for the base excess
element when calculating the PIM2 score to predict death
among a population of 2,380 children from a single English
PICU. Lactate significantly predicted mortality with an
odds ratio (OR) for death per unit (mmol/l) increase of 1.11
(95 % CI 1.06–1.16; p \ 0.001). Adding lactate to the
PIM2 model improved the fit of the model, with an
increase in area under the ROC curve from 0.832 to 0.848,
an example of how the PIM2 score may be usefully
modified to improve its performance further.
Modelling of capacity in health care is critical to the
efficient use of resources. One source of ‘inefficiency’ is
the readmission of patients to an ICU soon after primary
discharge. This is important information both for clini-
cians and health-care managers to have, as if readmission
rates are benchmarked against appropriate standards or
populations, high or low readmission rates may be a sign
of inefficient or unsafe systems of care. PICU readmission
may of course follow a genuinely unpredictable deterio-
ration, but may also result from preventable problems
including inappropriately precipitous ICU discharge or
poor quality care immediately following discharge. Bas-
tero-Minon et al. [69] determined that 2.45 % of 4,625
children discharged from a tertiary paediatric cardiac ICU
were readmitted within 72 h of their primary discharge.
Respiratory deterioration was the most common cause of
ICU readmission within 72 h. In retrospect, changes were
detected on pre PICU discharge chest X-rays in 12.5 % of
these children, suggesting that different management
might have prevented discharge-readmission. Frequently
there is a lack of certainty on when a patient is ‘‘ready’’
for discharge or when it is ‘‘safe’’ for a patient to be
transferred. Although ‘readiness for discharge’ criteria
have been suggested, the operational complexity of indi-
vidual hospitals is likely to limit their applicability. The
baseline readmission rate, derived as it is from a large
paediatric cardiac ICU, is, however, very useful data
against which other providers may wish to benchmark
[69].
Tibby et al. [70] highlighted another issue relevant to
PICU capacity planning and care pathway development.
Using a competing risks model, the investigators sought
to determine whether mortality or morbidity of children
with Down syndrome differed from the non-Down pop-
ulation after adjusting for important confounding
variables. They found that children with Down syndrome
required a higher proportion of organ support than
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expected by disease severity at ICU admission, and that
deaths in the Down syndrome population occurred sig-
nificantly later than those in the non-Downs group. The
authors raise an intriguing ‘hibernation’ hypothesis to
explain their findings, suggesting that patients (e.g. Down
patients) who are able to trigger a prompt hibernation
response will tend to avoid death early in an episode of
critical illness, though at a cost of a greater requirement
for early organ support. This large study provides useful
data for PICU clinicians and managers who must take into
account the population prevalence of Down syndrome
when planning intensive care provision. Further explora-
tion of the hibernation hypothesis is warranted [70].
As well as child patient outcomes, clinicians need to
be aware of the potential impact on family members
associated with an episode of critical illness. Colville and
Pierce [71] undertook a longitudinal cohort study of the
one or other parent associated with intensive care
admission of 66 consecutive 7- to 17-year-olds. The sig-
nificant findings of this study are that nearly half of the
families were experiencing significant post-traumatic
stress 12 months after discharge, and that many experi-
enced delayed reactions suggesting that families need
longer-term monitoring and support.
SIRS and sepsis in children
Shime et al. [72] recently provided an overview of the
incidence and mortality in paediatric severe sepsis using
data drawn from the Japanese national paediatric inten-
sive care registry. A total of 167 patients were studied
who matched definitions of paediatric severe sepsis
(systemic inflammatory response syndrome with cardio-
vascular dysfunction, ARDS or other multiorgan
dysfunction caused by infection) as defined by the Inter-
national Consensus Conference on Pediatric Sepsis, 2005
[73]. The incidence of severe sepsis was 1.4 % of PICU
admissions. Crude 28-day mortality was 18.9 %, com-
parable to PIM2 predicted mortality of 17.7 %. Children
with shock associated with haematological disorders and
those presenting in shock had a poor prognosis. Well-
managed registries are increasingly important in paedi-
atric critical care research. Standard data sets and data
management rules allow inter-unit, inter-regional or
international comparison of outcomes or permit patients
suitable for studies to be identified. This is perhaps even
more valuable in paediatric critical care than in adult care,
as the numbers of patients are far fewer, including some
with very rare conditions which cannot be properly
studied unless data from large populations are available.
Gatterre et al. [74] provide an interesting insight into the
presentation of rare severe forms of Kawasaki disease: 11
cases with the majority presenting in shock and multiple
organ dysfunction syndrome (MODS). This is a timely
reminder that Kawasaki disease should be considered in the
differential diagnosis of children presenting with shock or
organ dysfunction. Paize et al. [75] recently presented an
elegant study of the microcirculation in paediatric severe
meningococcal disease, comparing findings in this cohort
with healthy controls. Microcirculatory insufficiency cor-
related with markers of endothelial activation, and showed
longitudinal improvement as disease resolved. Whilst these
findings are interesting, further work is required to deter-
mine whether the assessment of microcirculatory
parameters can be relied upon to guide resuscitation and
ongoing therapy in sepsis or other shock states. Finally,
prevention of SIRS is clearly better than ‘cure’; Jack and
colleagues [76] describe how the use of in-line filtration
reduces complications and length of stay in critically ill
children admitted to a PICU and receiving intravenous
therapy. A total of 807 children were randomly allocated to
a control or filter group, with the latter receiving in-line
filtration. The incidence of predefined complications
including SIRS was lower in the filtered patients (40.9 vs.
30.9 %, p = 0.003). Another interesting aspect of paedi-
atric critical care was raised by Lombel et al. [77] in a
paper comparing different fluid overload definitions. Surely
we know how to measure fluid overload in children in
2012? Apparently not: Lombel studied four weight-based
definitions and four fluid-based definitions in 21 children
undergoing renal replacement therapy. The number of
patients considered to have greater than 10 % fluid over-
load ranged from 14 to 48 % depending on the definition
used; percentage fluid overload was not significantly
associated with PICU mortality but five of eight fluid
overload definitions were predictive of higher subsequent
PELOD scores. Further studies are urgently needed to
determine the optimal definition of fluid overload in criti-
cally ill children.
Neurology
Seizures are common in comatose children but may be
clinically subtle or detectable only with continuous EEG
monitoring. Kirkham et al. [78] addressed this important
issue reporting the use of continuous 1–3 channel EEG
monitoring in a series of 204 head-injured children. Of
these, 74 % were found to have electroencephalographic
seizures (ES), the majority without recognisable clinical
signs. Most of the children had clinical seizures (CS)
before EEG monitoring, but five had only ES, i.e. no CS.
The presence of unfavourable outcome was independently
predicted by the presence of ES. Further research looking
at the reliability of one- or two-channel cEEG monitoring
devices in diagnosing non-convulsive seizures is required
as the technical issues are resolved and our data add to the
evidence that outcome may be predicted on the PICU. In
another EEG-based study, Gunn et al. [79] reported on the
relationship between perioperative electrical seizures, the
background pattern of the amplitude-integrated EEG and
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2-year developmental outcome in young infants under-
going congenital heart surgery. CPB was used in 83 % of
cases. Perioperative electrical seizures were detected in
30 % of cases, of whom 25 % had clinically apparent
seizures. The occurrence of seizures did not correlate with
2-year neurodevelopmental outcome assessed using
Bayley Scales of Infant Development [79].
Sedation and analgesia
Accumulation of commonly used opioids can be a problem
in paediatric intensive care, especially in children with
renal or hepatic impairment. Fentanyl for instance has a
context-sensitive elimination half-life which increases with
time. Remifentanil is a potent opioid with an exceptionally
short half-life of 3–5 min with no evidence of prolongation
with time. Welzing et al. [80] compared a sedative
analgesic combination of fentanyl–midazolam with remif-
entanil–midazolam in a randomised double-blind study
conducted in 23 infants. Although designed as a pilot
study, the mean extubation time was significantly shorter in
the remifentanil group compared to the fentanyl group (80
vs. 782 min, p = 0.005). Both groups showed comparable
sedation score, good haemodynamic stability and low rates
of side effects. If these results are confirmed in a larger
study, remifentanil may be the potent opioid of choice in
mechanically ventilated infants. Sedatives are almost cer-
tainly overused in paediatric intensive care whilst the
causes of distress including delirium may be overlooked
and therefore undertreated. Silver et al. [81] described the
use of a simple rapid assessment tool, the Cornell
Assessment of Pediatric Delirium tool, for the detection of
delirium in 50 paediatric intensive care patients. There was
excellent concordance (97 %) between the new tool and
the reference standard (DSM-IV), which requires a lengthy
psychiatric evaluation. Further studies of this potentially
very valuable screening tool are required to confirm its
validity and establish inter-rater reliability and practicality
of use by bedside clinicians.
Endocrine
Measured deficiency tempts intensivists to replace,
examples being cortisol, thyroid hormone, albumin and
vitamins. Evidence on which clinical practice is based is
often weak but the compulsion to ‘normalise’ is powerful.
Karaguzel et al. [82] investigated the incidence of adrenal
insufficiency (AI) in three groups of children: 23 with
acute critical illness with severe sepsis, 27 with acute
critical illness without sepsis and 24 patients following
major surgery. Baseline cortisol was measured on
admission and then a low-dose ACTH stimulation test
was performed. Serial cortisol and ACTH levels were
then followed up to 14 days. The authors found that AI,
defined as an increment in cortisol level less than 9 lg/dl
following low-dose ACTH testing, occurred in 28 % of
patients with acute stress related to these three specific
conditions. As previously reported by Menon et al. [83],
the lowest rate of AI was seen in sepsis patients, sug-
gesting that the presence of sepsis was not associated with
an increased risk of AI. Whether treatment of AI in crit-
ically ill children is required is, however, unclear. Rippel
et al. [84] also tempts us to consider replacement, this
time with a report of the incidence of vitamin D defi-
ciency in a critically ill population. Hypovitaminosis D is
common in critically ill adults. Rippel et al. measured
vitamin D levels in 316 children and determined that
levels were low in 34.5 % of the study population.
Hypovitaminosis D was not, however, associated with
differences in PICU length of stay or hospital survival.
Further studies of hypovitaminosis D are warranted,
especially in children undergoing cardiac surgery or with
existing cardiac dysfunction.
Miscellanea
Controversy exists over how to ‘clear’ (we mean enable
the clinician to safely remove spinal precautions based on
imaging and/or clinical examination) the spine of signif-
icant unstable injury among clinically unevaluable
obtunded blunt trauma patients (OBTPs). To clear the
spine in this clinical scenario largely centres on imaging,
possibly supported by clinical evaluation if and when
patients become evaluable. The review by Plumb and
Morris [85] provides a clinically relevant update of the
available evidence since 2004. Plain radiography has
low sensitivity for detecting unstable spinal injuries
in OBTPs, whereas multidetector-row computerised
tomography (MDCT) approaches 100 % sensitivity.
Magnetic resonance imaging (MRI) is inferior to MDCT
for detecting bony injury but superior for detecting soft
tissue injury with a sensitivity approaching 100 %,
although 40 % of such injuries may be stable and ‘false
positive’. In studies comparing MDCT with MRI for
OBTPs, MRI following ‘normal’ CT may detect up to
7.5 % of missed injuries with an operative fixation in
0.29 % and prolonged collar application in 4.3 %.
Increasing data is available on the complications associ-
ated with prolonged spinal immobilisation among a
population where a minority have an actual injury. It was
concluded that given the variability of screening perfor-
mance it remains acceptable for clinicians to clear the
spine of OBTPs using MDCT alone or MDCT followed
by MRI, with implications for either approach. With all
screening processes false positive and false negative
results will occur and have consequences. It is essential
that clinicians and institutions audit their data to deter-
mine their likely screening performances in practice.
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Regional citrate anticoagulation (RCA) is an attractive
anticoagulation mode in continuous renal replacement
therapy (CRRT) because it restricts the anticoagulatory
effect to the extracorporeal circuit and may decrease the
heparin-induced risks such as bleeding and thrombocy-
topaenia. Zhang and Hongying [86] performed a
systematic review and meta-analysis of randomised con-
trolled trials comparing the efficacy and safety of CRRT
anticoagulation therapies. The intervention treatment was
RCA and the end-points were circuit life span, bleeding
events, metabolic complications and mortality. Six studies
met the inclusion criteria, which involved a total of 658
circuits. Patients with liver failure or a high risk of
bleeding were excluded. The circuit life span in the RCA
group was significantly longer than that in the control
group, with a mean difference of 23.03 h (95 % CI
0.45–45.61 h), but much heterogeneity was found among
studies. RCA was able to reduce the risk of bleeding, with
a risk ratio of 0.28 (95 % CI 0.15–0.50). RCA was
associated with more episodes of hypocalcaemia. Two
studies compared the mortality rate between RCA and
control groups, with one reporting similar mortality rate
and the other reporting superiority of RCA over the
control group. It was concluded that RCA is effective
in maintaining circuit patency and reducing the risk of
bleeding, and the impact on mortality is controversial.
Brotschi and co-workers [87] tested whether an in-line
filter that was inserted in the syringe infusion pump line
will influence start-up times and also flow irregularities at
low infusion rates. The authors conclude that the in-line
filters helped to reduce flow irregularities but also, and
more surprisingly at first glance, a delay in drug delivery.
This may be particularly important when highly concen-
trated drugs are administered at low flow rates.
Mallat and co-workers [88] studied the anion gap in
critically ill patients and determined the smallest detect-
able change (SDD) in individual patients. They had a
large sample with 161 patients and studied the repeat-
ability by different mathematical expressions and their
conclusion was that repeatability was good and that SDD
was an appropriate determinant of the sensitivity or pre-
cision of the technique. It was preferable to the coefficient
of variation and ‘‘least significant change’’ because of
their dependence on the levels of the variables. All in all,
measurements of the anion gap according to Stewart’s
parameter could thus be used to continuously follow
intensive care patients.
Hyperbaric environment
The role of hyperbaric oxygen therapy in necrotising soft
tissue infections (NSTI) was analysed by Soh et al. [89] to
determine the effect of hyperbaric oxygen (HBO) therapy
on mortality, complication rate, discharge status/location,
hospital length of stay (LOS) and inflation-adjusted hos-
pitalisation cost in patients with NSTI in a retrospective
study of 45,913 patients in the US Nationwide Inpatient
Sample (NIS) from 1988 to 2009. A total of 405 patients
received HBO therapy. The patients with NSTI who
received HBO therapy had a lower mortality (4.5 vs.
9.4 %, p = 0.001). After adjusting for predictors and
confounders, the authors found that patients who received
HBO therapy had a statistically significantly lower risk of
dying, higher hospitalisation cost (US$52,205 vs.
US$45,464, p = 0.02) and longer LOS. Despite the last
two factors, the statistically significant reduction in mor-
tality supports the use of HBO therapy.
In a bench study Lefebvre and co-workers [90] tested
a hyperbaric chamber ventilator at different atmospheric
pressures. With increasing gas density by raising the gas
pressure the resistance increases in the ventilator and
reduces the flow delivered by the ventilator. A new
machine (Siaretron IPER 1000) has a built-in compen-
satory technique to deliver a preset flow irrespective of
atmospheric pressure. Tests covering a range from 1 to 4
atmospheres showed the ventilator to be reliable within a
certain range of gas flows. Outside this range tidal volume
and minute ventilation were reduced.
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